{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:20:11Z","timestamp":1790292011590,"version":"4.1.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroradiology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.neurad.2021.01.006","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T18:23:03Z","timestamp":1611858183000},"page":"369-378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Imaging of IgG4-Related Disease in the Head and Neck: A Systematic Review, Case Series, and Pathophysiology Update"],"prefix":"10.1016","volume":"48","author":[{"given":"Fardad","family":"Behzadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong Hyun","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vickie Y.","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vignesh","family":"Shanmugam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4684-5469","authenticated-orcid":false,"given":"Jeffrey P.","family":"Guenette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurad.2021.01.006_bib0005","first-page":"1181","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"key":"10.1016\/j.neurad.2021.01.006_bib0010","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1002\/art.39773","article-title":"Association of IgG4-Related Disease With History of Malignancy","volume":"68","author":"Wallace","year":"2016","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"issue":"3","key":"10.1016\/j.neurad.2021.01.006_bib0015","first-page":"253","article-title":"IgG-4 Related Disease: An Introduction","volume":"115","author":"Al-Khalili","year":"2018","journal-title":"Mo Med"},{"key":"10.1016\/j.neurad.2021.01.006_bib0020","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1056\/NEJM200103083441005","article-title":"High serum IgG4 concentrations in patients with sclerosing pancreatitis","volume":"344","author":"Hamano","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurad.2021.01.006_bib0025","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-related disease","volume":"366","author":"Stone","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurad.2021.01.006_bib0030","first-page":"1","article-title":"Head and neck immunoglobulin G4 related disease: systematic review","author":"Tirelli","year":"2018","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.neurad.2021.01.006_bib0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40463-015-0071-9","article-title":"Immunoglobulin G4-related diseases in the head and neck: a systematic review","volume":"44","author":"Mulholland","year":"2015","journal-title":"J Otolaryngol - Head Neck Surg J Oto-Rhino-Laryngol Chir Cervico-Faciale"},{"key":"10.1016\/j.neurad.2021.01.006_bib0040","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.crad.2017.04.004","article-title":"Imaging of IgG4-related disease of the head and neck","volume":"73","author":"Thompson","year":"2018","journal-title":"Clin Radiol"},{"key":"10.1016\/j.neurad.2021.01.006_bib0045","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.neurad.2021.01.006_bib0050","first-page":"203","article-title":"Overview of IgG4 - Related Disease","volume":"10","author":"Opri\u0163\u0103","year":"2017","journal-title":"J Med Life"},{"key":"10.1016\/j.neurad.2021.01.006_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/358371","article-title":"Prevalence of IgG4-Related Disease in Japan Based on Nationwide Survey in 2009","volume":"2012","author":"Uchida","year":"2012","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.neurad.2021.01.006_bib0060","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/annrheumdis-2018-214603","article-title":"Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts","volume":"78","author":"Wallace","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.neurad.2021.01.006_bib0065","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.reuma.2016.05.009","article-title":"IgG4-related disease: A concise review of the current literature","volume":"13","author":"Ardila-Suarez","year":"2017","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.neurad.2021.01.006_bib0070","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaci.2018.05.011","article-title":"Identification of galectin-3 as an autoantigen in patients with IgG4-related disease","volume":"143","author":"Perugino","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.neurad.2021.01.006_bib0075","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s40266-018-0534-6","article-title":"IgG4-Related Disease: Beyond Glucocorticoids","volume":"35","author":"Akiyama","year":"2018","journal-title":"Drugs Aging"},{"key":"10.1016\/j.neurad.2021.01.006_bib0080","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","article-title":"Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011","volume":"22","author":"Umehara","year":"2012","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.neurad.2021.01.006_bib0085","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/annrheumdis-2013-204907","article-title":"The diagnostic utility of serum IgG4 concentrations in IgG4-related disease","volume":"74","author":"Carruthers","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.neurad.2021.01.006_bib0090","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.41120","article-title":"The 2019 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for IgG4-Related Disease","volume":"72","author":"Wallace","year":"2020","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.neurad.2021.01.006_bib0095","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/art.39132","article-title":"International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease","volume":"67","author":"Khosroshahi","year":"2015","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.neurad.2021.01.006_bib0100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/BOR.0b013e328341a240","article-title":"Treatment approaches to IgG4-related systemic disease","volume":"23","author":"Khosroshahi","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.neurad.2021.01.006_bib0105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/MD.0b013e3182431ef6","article-title":"Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients","volume":"91","author":"Khosroshahi","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.neurad.2021.01.006_bib0110","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/art.27435","article-title":"Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease","volume":"62","author":"Khosroshahi","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.neurad.2021.01.006_bib0115","doi-asserted-by":"crossref","first-page":"rkz014","DOI":"10.1093\/rap\/rkz014","article-title":"Retrospective single-centre analysis of IgG4-related disease patient population and treatment outcomes between 2007 and 2017","volume":"3","author":"Lee","year":"2019","journal-title":"Rheumatol Adv Pract"},{"key":"10.1016\/j.neurad.2021.01.006_bib0120","article-title":"IgG4-Related Disease: Is Rituximab the Best Therapeutic Strategy for Cases Refractory to Conventional Therapy? Results of a Systematic Review","author":"Betancur-V\u00e1squez","year":"2019","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.neurad.2021.01.006_bib0125","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m1067","article-title":"Advances in the diagnosis and management of IgG4 related disease","author":"Lanzillotta","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.neurad.2021.01.006_bib0130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/MNM.0b013e32835a2eea","article-title":"Comparison between sarcoidosis and IgG4-related disease by whole-body 67Ga scintigraphy","volume":"34","author":"Ishii","year":"2013","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.neurad.2021.01.006_bib0135","doi-asserted-by":"crossref","first-page":"W276","DOI":"10.2214\/AJR.11.8321","article-title":"Systemic IgG4-Related Sclerosing Disease: Spectrum of Imaging Findings and Differential Diagnosis","volume":"199","author":"Horger","year":"2012","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.neurad.2021.01.006_bib0140","first-page":"119","article-title":"Utility of FDG-PET\/CT in the diagnosis of IgG4-related diseases","volume":"34","author":"Zhao","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.neurad.2021.01.006_bib0145","first-page":"297","article-title":"Usefulness of PET\/CT imaging in systemic IgG4-related sclerosing disease. A report of three cases","volume":"12","author":"Nguyen","year":"2011","journal-title":"JOP J Pancreas"},{"key":"10.1016\/j.neurad.2021.01.006_bib0150","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1007\/s00259-014-2729-3","article-title":"Characterizing IgG4-related disease with 18F-FDG PET\/CT: a prospective cohort study","volume":"41","author":"Zhang","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.neurad.2021.01.006_bib0155","first-page":"731","article-title":"Localized or diffuse lesions of the submandibular glands in immunoglobulin g4-related disease in association with differential organ involvement","volume":"32","author":"Asai","year":"2013","journal-title":"J Ultrasound Med Off J Am Inst Ultrasound Med"},{"key":"10.1016\/j.neurad.2021.01.006_bib0160","first-page":"773","article-title":"IgG4-related Mikulicz\u2019s disease: ultrasonography of the salivary and lacrimal glands for monitoring the efficacy of corticosteroid therapy","volume":"31","author":"Takagi","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.neurad.2021.01.006_bib0165","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s13075-015-0751-x","article-title":"Effectiveness of imaging modalities for screening IgG4-related dacryoadenitis and sialadenitis (Mikulicz\u2019s disease) and for differentiating it from Sj\u00f6gren\u2019s syndrome (SS), with an emphasis on sonography","volume":"17","author":"Shimizu","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.neurad.2021.01.006_bib0170","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.tripleo.2009.02.032","article-title":"Sonographic diagnosis for Mikulicz disease","volume":"108","author":"Shimizu","year":"2009","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.neurad.2021.01.006_bib0175","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.1007\/s00330-018-5987-9","article-title":"Native T1 mapping of autoimmune pancreatitis as a quantitative outcome surrogate","volume":"29","author":"Zhu","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.neurad.2021.01.006_bib0180","doi-asserted-by":"crossref","first-page":"e4865","DOI":"10.1097\/MD.0000000000004865","article-title":"Gallium SPECT\/CT in evaluation of IgG4-related disease: A case report and literature review","volume":"95","author":"Chuang","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.neurad.2021.01.006_bib0185","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00234-012-1012-1","article-title":"Radiological features of IgG4-related disease in the head, neck, and brain","volume":"54","author":"Katsura","year":"2012","journal-title":"Neuroradiology"},{"key":"10.1016\/j.neurad.2021.01.006_bib0190","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s10384-012-0151-6","article-title":"The usefulness of infraorbital nerve enlargement on MRI imaging in clinical diagnosis of IgG4-related orbital disease","volume":"56","author":"Ohshima","year":"2012","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.neurad.2021.01.006_bib0195","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/bjophthalmol-2012-302857","article-title":"Ocular adnexal IgG4-related disease: CT and MRI findings","volume":"97","author":"Song","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.neurad.2021.01.006_bib0200","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/archopht.125.11.1575","article-title":"Sugiyama K. IgG4-Related Chronic Sclerosing Dacryoadenitis","volume":"125","author":"Takahira","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.neurad.2021.01.006_bib0205","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.3174\/ajnr.A3147","article-title":"MR Imaging of IgG4-Related Disease in the Head and Neck and Brain","volume":"33","author":"Toyoda","year":"2012","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.neurad.2021.01.006_bib0210","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.18240\/ijo.2020.08.08","article-title":"CT and MR imaging findings of ocular adnexal mucosa-associated lymphoid tissue lymphoma associated with IgG4-related disease: multi-institutional case series","volume":"13","author":"Yoo","year":"2020","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.neurad.2021.01.006_bib0215","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/acr.20215","article-title":"Riedel\u2019s thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum","volume":"62","author":"Dahlgren","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.neurad.2021.01.006_bib0220","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.2169\/internalmedicine.52.0902","article-title":"IgG4-related ocular adnexal disease mimicking thyroid-associated orbitopathy","volume":"52","author":"Inaba","year":"2013","journal-title":"Intern Med Tokyo Jpn"},{"key":"10.1016\/j.neurad.2021.01.006_bib0225","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1007\/s00259-019-04600-4","article-title":"Isolated involvement of thyroid gland by IgG4-related disease revealed by 18F-FDG PET\/CT","volume":"47","author":"Jiang","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.neurad.2021.01.006_bib0230","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1210\/jc.2009-1794","article-title":"Distinct clinical, serological, and sonographic characteristics of hashimoto\u2019s thyroiditis based with and without IgG4-positive plasma cells","volume":"95","author":"Li","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.neurad.2021.01.006_bib0235","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1590\/0004-2730000003283","article-title":"IgG4-related Hashimoto\u2019s thyroiditis--a new variant of a well known disease","volume":"58","author":"Luiz","year":"2014","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.neurad.2021.01.006_bib0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/5382640","article-title":"Clinical Characteristics of 76 Patients with IgG4-Related Hypophysitis: A Systematic Literature Review","volume":"2019","author":"Li","year":"2019","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.neurad.2021.01.006_bib0245","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3457046","article-title":"Hypophyseal Involvement in Immunoglobulin G4-Related Disease: A Retrospective Study from a Single Tertiary Center","author":"Liu","year":"2018","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.neurad.2021.01.006_bib0250","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1507\/endocrj.K09E-277","article-title":"Pituitary and Stalk Lesions (Infundibulo-hypophysitis) Associated with Immunoglobulin G4-related Systemic Disease: an Emerging Clinical Entity","volume":"56","author":"Shimatsu","year":"2009","journal-title":"Endocr J"},{"key":"10.1016\/j.neurad.2021.01.006_bib0255","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.2500\/ar.2012.3.0026","article-title":"Locally destructive skull base lesion: IgG4-related sclerosing disease","volume":"3","author":"Alt","year":"2012","journal-title":"Allergy Rhinol"},{"key":"10.1016\/j.neurad.2021.01.006_bib0260","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.wneu.2019.10.111","article-title":"IgG4-Related Disease of Skull Base: Case Series of 3 Patients with Headache","volume":"134","author":"Detiger","year":"2020","journal-title":"World Neurosurg"},{"key":"10.1016\/j.neurad.2021.01.006_bib0265","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1007\/s00405-016-4033-2","article-title":"IgG4-related disease presenting with destructive sinonasal lesion mimicking malignancy","volume":"273","author":"Chen","year":"2016","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.neurad.2021.01.006_bib0270","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.advms.2017.04.001","article-title":"Clinical features of IgG4-related rhinosinusitis","volume":"62","author":"Hanaoka","year":"2017","journal-title":"Adv Med Sci"},{"key":"10.1016\/j.neurad.2021.01.006_bib0275","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1440-1827.2009.02425.x","article-title":"Multiple IgG4-related sclerosing lesions in the maxillary sinus, parotid gland and nasal septum","volume":"59","author":"Ishida","year":"2009","journal-title":"Pathol Int"},{"key":"10.1016\/j.neurad.2021.01.006_bib0280","doi-asserted-by":"crossref","first-page":"E321","DOI":"10.1002\/hed.23175","article-title":"Immunoglobulin G4-related sclerosing disease of the paranasal sinus","volume":"35","author":"Lindau","year":"2013","journal-title":"Head Neck"},{"key":"10.1016\/j.neurad.2021.01.006_bib0285","first-page":"151","article-title":"A rare and emerging entity: Sinonasal IgG4-related sclerosing disease","volume":"6","author":"Song","year":"2015","journal-title":"Allergy Rhinol Provid RI"},{"key":"10.1016\/j.neurad.2021.01.006_bib0290","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1259\/bjr\/38960620","article-title":"MRI of chronic sclerosing sialoadenitis","volume":"81","author":"Abu","year":"2008","journal-title":"Br J Radiol"},{"key":"10.1016\/j.neurad.2021.01.006_bib0295","first-page":"783","article-title":"Sonographic evaluation of the treatment response in patients with immunoglobulin G4-related disease of the submandibular glands","volume":"34","author":"Asai","year":"2015","journal-title":"J Ultrasound Med Off J Am Inst Ultrasound Med"},{"key":"10.1016\/j.neurad.2021.01.006_bib0300","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s13075-015-0698-y","article-title":"Clinicopathological characteristics of immunoglobulin G4-related sialadenitis","volume":"17","author":"Li","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.neurad.2021.01.006_bib0305","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s12149-015-0969-3","article-title":"Role of F-18 FDG PET\/CT in assessing IgG4-related disease with inflammation of head and neck glands","volume":"29","author":"Tokue","year":"2015","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.neurad.2021.01.006_bib0310","author":"Yorihisa Orita","year":"2020","journal-title":"Ear Nose Throat J"},{"key":"10.1016\/j.neurad.2021.01.006_bib0315","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.crad.2011.10.011","article-title":"Utility of FDG PET\/CT in IgG4-related systemic disease","volume":"67","author":"Nakatani","year":"2012","journal-title":"Clin Radiol"},{"key":"10.1016\/j.neurad.2021.01.006_bib0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3941\/jrcr.v11i7.3147","article-title":"A Case Report of Mikulicz Syndrome","volume":"11","author":"Rao","year":"2017","journal-title":"J Radiol Case Rep"},{"key":"10.1016\/j.neurad.2021.01.006_bib0325","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3109\/14397595.2013.865884","article-title":"A study of infraorbital nerve swelling associated with immunoglobulin G4 Mikulicz\u2019s disease","volume":"24","author":"Takano","year":"2014","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.neurad.2021.01.006_bib0330","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3109\/s10165-010-0410-7","article-title":"A case of IgG4-related disease with features of Mikulicz\u2019s disease, and retroperitoneal fibrosis and lymphadenopathy mimicking Castleman\u2019s disease","volume":"21","author":"Takenaka","year":"2011","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.neurad.2021.01.006_bib0335","first-page":"1945","article-title":"IgG4-related disease of the head and neck: CT and MR imaging manifestations","volume":"32","author":"Fujita","year":"2012","journal-title":"Radiogr Rev Publ Radiol Soc N Am Inc"},{"key":"10.1016\/j.neurad.2021.01.006_bib0340","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/jamaoto.2018.2258","article-title":"Pediatric Laryngeal Expression and Surgical Treatment of IgG4-Related Disease","volume":"144","author":"Jordan","year":"2018","journal-title":"JAMA Otolaryngol-- Head Neck Surg"},{"key":"10.1016\/j.neurad.2021.01.006_bib0345","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/0003489414549574","article-title":"Clinical Manifestations of IgG4-Related Disease in the Pharynx: Case Series and Review of the Literature","volume":"124","author":"Reder","year":"2015","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.neurad.2021.01.006_bib0350","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00234-017-1921-0","article-title":"Imaging findings of primary immunoglobulin G4-related cervical lymphadenopathy","volume":"59","author":"Kawaguchi","year":"2017","journal-title":"Neuroradiology"},{"key":"10.1016\/j.neurad.2021.01.006_bib0355","doi-asserted-by":"crossref","DOI":"10.1186\/s13000-016-0493-3","article-title":"Diagnostic dilemma of IgG4-related primary localized cervical lymphadenopathy associated with aberrant IL-6 expression level","volume":"11","author":"Nakamura","year":"2016","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.neurad.2021.01.006_bib0360","article-title":"IgG4-related disease in a patient with HIV infection","volume":"12","author":"Ron","year":"2019","journal-title":"BMJ Case Rep CP"},{"key":"10.1016\/j.neurad.2021.01.006_bib0365","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.anl.2015.02.010","article-title":"A case of progressively transformed germinal center-type IgG4-related lymphadenopathy","volume":"42","author":"Seki","year":"2015","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.neurad.2021.01.006_bib0370","first-page":"543","article-title":"Clinical features of hypertrophic pachymeningitis in a center survey","volume":"40","author":"Ca\u00e7\u00e3o","year":"2019","journal-title":"Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol"},{"key":"10.1016\/j.neurad.2021.01.006_bib0375","doi-asserted-by":"crossref","first-page":"87","DOI":"10.14791\/btrt.2014.2.2.87","article-title":"Immunoglobulin G4-Related Hypertrophic Pachymeningitis with Skull Involvement","volume":"2","author":"Lee","year":"2014","journal-title":"Brain Tumor Res Treat"},{"key":"10.1016\/j.neurad.2021.01.006_bib0380","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.semarthrit.2019.05.003","article-title":"Clinical presentation, treatment and outcome of IgG4-related pachymeningitis: From a national case registry and literature review","volume":"49","author":"Melenotte","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.neurad.2021.01.006_bib0385","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2482-13-37","article-title":"IgG4-related intracranial hypertrophic pachymeningitis with skull hyperostosis: a case report","volume":"13","author":"Lin","year":"2013","journal-title":"BMC Surg"},{"key":"10.1016\/j.neurad.2021.01.006_bib0390","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fneur.2014.00192","article-title":"Bilateral Vision Loss Secondary to Pachymeningitis in a Patient with IgG4-Related Disease","volume":"5","author":"Ramirez","year":"2014","journal-title":"Front Neurol"},{"key":"10.1016\/j.neurad.2021.01.006_bib0395","doi-asserted-by":"crossref","first-page":"e568","DOI":"10.1212\/NXI.0000000000000568","article-title":"Immunoglobulin G4-related hypertrophic pachymeningitis: A case-oriented review","volume":"6","author":"Levraut","year":"2019","journal-title":"Neurol - Neuroimmunol Neuroinflammation"},{"key":"10.1016\/j.neurad.2021.01.006_bib0400","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.wneu.2019.06.130","article-title":"Spinal IgG4-Related Hypertrophic Pachymeningitis with Spinal Cord Compression: Case Report and Literature Review","volume":"130","author":"Slade","year":"2019","journal-title":"World Neurosurg"},{"key":"10.1016\/j.neurad.2021.01.006_bib0405","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.wneu.2019.08.127","article-title":"Intracranial Multiple Pseudotumor Due to Immunoglobulin G4-Related Disease without Other Lesions: Case Report and Literature Review","volume":"132","author":"Kuroda","year":"2019","journal-title":"World Neurosurg"},{"key":"10.1016\/j.neurad.2021.01.006_bib0410","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s11604-013-0191-y","article-title":"IgG4-related inflammatory pseudotumors mimicking multiple meningiomas","volume":"31","author":"Nishino","year":"2013","journal-title":"Jpn J Radiol"},{"key":"10.1016\/j.neurad.2021.01.006_bib0415","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1177\/0003489416672476","article-title":"IgG4-Related Disease of Bilateral Temporal Bones","volume":"126","author":"Li","year":"2017","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.neurad.2021.01.006_bib0420","article-title":"IgG4-related disease is a rare cause of recurrent mastoiditis and can be mimicked by severe otitis media","author":"Zane","year":"2013","journal-title":"Lab Invest"},{"key":"10.1016\/j.neurad.2021.01.006_bib0425","article-title":"IgG4-related disease presenting as otogenic skull base osteomyelitis","author":"Yim","year":"2020","journal-title":"Auris Nasus Larynx"}],"container-title":["Journal of Neuroradiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0150986121000316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0150986121000316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:45:28Z","timestamp":1758969928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0150986121000316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":85,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0150986121000316"],"URL":"https:\/\/doi.org\/10.1016\/j.neurad.2021.01.006","relation":{},"ISSN":["0150-9861"],"issn-type":[{"value":"0150-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imaging of IgG4-Related Disease in the Head and Neck: A Systematic Review, Case Series, and Pathophysiology Update","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroradiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurad.2021.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}